Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

Nicola Logallo(Haukeland University Hospital), Vojtěch Novotný(Haukeland University Hospital), Jörg Aßmus(Haukeland University Hospital), Christopher Elnan Kvistad(Haukeland University Hospital), Lars Alteheld(Oslo University Hospital), Ole Morten Rønning(Akershus University Hospital), Bente Thommessen(Akershus University Hospital), Karl-Friedrich Amthor(Drammen Hospital), Hege Ihle‐Hansen(Vestre Viken Hospital Trust), Martin Kurz(Stavanger University Hospital), Håkon Tobro(Telemark Hospital), Kamaljit Kaur(Privatsykehuset Haugesund), Magdalena Stankiewicz(Helse Førde), Maria Carlsson(Nordland Hospital), Åse Hagen Morsund(Helse Møre og Romsdal HF), Titto Idicula(St Olav's University Hospital), Anne Hege Aamodt(Oslo University Hospital), Christian Lund(Oslo University Hospital), Halvor Næss(Stavanger University Hospital), Ulrike Waje‐Andreassen(Haukeland University Hospital), Lars Thomassen(University of Bergen)
The Lancet Neurology
August 2, 2017
Cited by 464

Abstract


Related Papers

No related papers found

Powered by citation graph analysis